Cited by 208Liver physiology and pathologyPluripotent Stem Cells ResearchTissue Engineering and Regenerative Medicine

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis

Open access
Song, Guangqi, Pacher, Martin, Balakrishnan, Asha, Yuan, Qinggong, Tsay, Hsin-Chieh, Yang, Dakai, Reetz, Julia, Brandes, Sabine +12 more·2016·Cell Stem Cell

Abstract

Direct induction of induced hepatocytes (iHeps) from fibroblasts holds potential as a strategy for regenerative medicine but until now has only been shown in culture settings. Here, we describe in vivo iHep formation using transcription factor induction and genetic fate tracing in mouse models of chronic liver disease. We show that ectopic expression of the transcription factors FOXA3, GATA4, HNF1A, and HNF4A from a polycistronic lentiviral vector converts mouse myofibroblasts into cells with a hepatocyte phenotype. In vivo expression of the same set of transcription factors from a p75 neurotrophin receptor peptide (p75NTRp)-tagged adenovirus enabled the generation of hepatocyte-like cells from myofibroblasts in fibrotic mouse livers and reduced liver fibrosis. We have therefore been able to convert pro-fibrogenic myofibroblasts in the liver into hepatocyte-like cells with positive functional benefits. This direct in vivo reprogramming approach may open new avenues for the treatment of chronic liver disease.

Integrity signals

Registry

Crossref · 10.1016/j.stem.2016.01.010

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes.

    “Recent progress has shown that liver transcription factor overexpression can reprogram fibroblasts into more mature hepatocytes (Huang et al., 2014; Sekiya and Suzuki, 2011; Song et al., 2016; Yu et al., 2013; Zhu et al., 2014).”

    From A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells (2018) · cites this paper as Song et al., 2016

  • Increased glycolysis has been implicated in experimental lung, liver, and kidney fibrosis models, and inhibition of glycolysis reduces extracellular matrix accumulation.

    “Increased glycolysis has been implicated in experimental lung, liver and kidney fibrosis models and inhibition of glycolysis reduces ECM accumulation50–52.”

    From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [51]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Song, G., Pacher, M., Balakrishnan, A., Yuan, Q., Tsay, H.-C., Yang, D., Reetz, J., Brandes, S., Dai, Z., Pützer, B. M., Araúzo-Bravo, M. J., Steinemann, D., Luedde, T., Schwabe, R. F., Manns, M. P., Schöler, H. R., Schambach, A., Cantz, T., Ott, M., & Sharma, A. D.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • Universitätsmedizin Rostock (DE)
  • Ikerbasque (ES)
  • Universitätsklinikum Aachen (DE)
  • Columbia University (US)
  • Max Planck Institute for Molecular Biomedicine (DE)
Corresponding author
  • Ott, Michael
  • Sharma, Amar Deep
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2016-06
Volume
18
Issue
6
Pages
797-808
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2278964323
Cited by
208
References
34
Citations by year
2026: 4 · 2025: 16 · 2024: 17 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 21 · 2018: 25 · 2017: 31 · 2016: 19
FWCI
23.06
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • Max Planck Institute for Plasma Physics (submittedVersion)
  • RWTH Publications (RWTH Aachen) (submittedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (SFB-738, DFG SH640/1-2, DFG 188/9-1, DFG EXC 62/2)
  • Bundesministerium für Bildung und Forschung
  • China Scholarship Council
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
direct reprogramming, myofibroblasts, hepatocytes, liver fibrosis, transcription factors, FOXA3, GATA4, HNF1A, HNF4α, p75 neurotrophin receptor, adenoviral vector, lentiviral vectors, chronic liver disease, hepatocyte-like cells
MeSH terms
Dependovirus, Animals, Cholestasis, Dicarbethoxydihydrocollidine, Liver, Liver Cirrhosis, Mice, Inbred BALB C, Mice, Transgenic, Models, Biological, Transcription Factors, Biomarkers, Cell Lineage, Integrases, Oligonucleotide Array Sequence Analysis, Hepatocytes, Myofibroblasts, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review